Weight-loss medications such as Ozempic, Wegovy and Mounjaro have become increasingly popular, but new research suggests many users are not relying primarily on healthcare professionals for advice.

A UK study of people using GLP-1 medications found that social media, online forums, friends and family were common sources of information. Around 48% of participants said they used social media for guidance, while healthcare professionals were consulted less often.

The findings suggest that access to medication is expanding faster than access to reliable, ongoing support.

Social Media Fills the Gap

GLP-1 medications can reduce appetite and help regulate blood sugar, but they also come with practical questions that often continue long after a prescription is issued. Users want to know how to handle nausea, fatigue, changes in appetite, muscle loss, meal timing and exercise. They are also concerned about what happens if they stop taking the drugs and whether lost weight will return. Many participants said they turned to online communities because they could find real-life experiences from people dealing with the same issues.

That kind of peer support can be valuable, especially when users feel uncertain or isolated. But the quality of advice online varies widely.

High Satisfaction, Real Concerns

Despite those issues, satisfaction with the medications was generally high. Around 93% of participants reported positive effects on body weight, while 83% said the drugs had improved how they felt about their appearance.

At the same time, the study identified several warning signs. Nearly 62% said they skipped meals at least two or three times a week. Some also reported lower energy levels that affected exercise or ordinary daily activities.

More than 46% expressed concern about losing muscle mass. These findings matter because weight loss is not always the same as healthy weight loss. If food intake falls too sharply, users may struggle to consume enough protein, maintain muscle and stay physically active.

Muscle Loss Is a Major Worry

One of the biggest issues raised by participants was maintaining muscle while losing weight. GLP-1 medications can reduce hunger substantially, and some people may unintentionally eat much less than they need. If calorie intake falls sharply without enough protein or resistance exercise, some of the weight lost may come from lean tissue rather than body fаt alone.

Lead researcher Jason Tallis emphasized that users need practical support throughout treatment, not just access to medication. He argued that guidance should include advice on staying active, protecting muscle health, managing side effects and maintaining benefits over the longer term.

Online Pharmacies Are Common

The study also found that many participants obtained their medication through online pharmacies. That raised another concern: some users questioned how thorough the checks were before prescriptions were issued. A small proportion reported taking larger doses or using the medication more frequently than recommended because they felt the treatment was not working well enough.

That behavior can be risky. Dose changes should generally be based on clinical guidance because higher or more frequent dosing may increase the chance of side effects without necessarily producing better results.

Researchers warned that easier access to these medications needs to be matched by stronger safeguards and clearer patient education.

What Happens After Treatment?

Another major concern is what happens when people stop taking GLP-1 drugs. Participants worried about regaining weight, losing access to medication or being left without support once treatment ended. These concerns are understandable because appetite can increase again after medication is stopped, while habits around eating and physical activity may still need adjustment. Professor David Broom, who also contributed to the research, noted that weight-loss medications are clearly effective for many people in the short term.

However, he also pointed to concerns about inadequate screening before use and insufficient long-term support afterward. That makes follow-up care especially important.

Psychological Effects Matter Too

The research was not limited to physical side effects. Participants also described changes in confidence, body image and eating habits. Some people felt better about their appearance, while others had to adjust to a rapidly changing relationship with food. Online communities often became a place to discuss those experiences openly. That can provide emotional reassurance, but it also means that complex psychological questions may be handled by peers rather than trained professionals.

Better Support Is Needed

The broader message from the study is not that GLP-1 medications are ineffective. On the contrary, most users reported meaningful benefits. The problem is that support around them may not be keeping pace with demand. People need reliable information on nutrition, physical activity, side effects, dosing, muscle preservation and what to expect if treatment stops.